$NCPL ASCENDING TRIANGLE

$NFLX is in its largest drawdown in three years

$NFLX is in its largest drawdown in three years

$PTN Target price: $25 Support level: $21 The Phase III clinical trial data for this peptide drug exceeded expectations, and the company will submit a breakthrough therapy application to the U.S. Food and Drug Administration (FDA) next month.

$ENVB SETTING UP FOR A BREAKOUT!!

$ENVB Short-term trading target price: $15-20, Stop-loss price: $8 The EVM301 patent (N-heterocyclic tryptamine derivatives) has been approved by the U.S. Patent and Trademark Office. Buy now! ENVB is a high-yield stock suitable for short-term trading.

$ASPC Waiting for the downtrend line to be broken on closing, looking for good entry opportunities and larger price movements.

$GEMI Target Price: $15-20 Stop-loss Price: Below $10.50 This stock has significant upside potential and relatively low risk – a buy at the current price is recommended. What are your thoughts on $GEMI's transformation?

$PL Recommended to buy in batches. Target price: $15-18 Stop-loss set below $12

$AIRJ Target Price: $11.50 The long-term downtrend line has bottomed out and rebounded, and the recent appearance of green candlesticks indicates a potential bottom reversal signal.

$PL From a technical perspective, this is a very standard "W-shaped bottom + platform breakout + pullback confirmation" pattern. The entire accumulation-consolidation-rally cycle fits perfectly. Aggressive traders can enter the market directly at today's closing price; any price

$AIRJ This is a typical "bull market pullback": after a rapid price increase, a large-volume bearish candlestick appeared at the top, resembling a "flag" or "head and shoulders" pattern. The price then rebounded slightly in the 3.10-3.77 range; observe whether it can effectively

$MITK Momentum is strong, approaching overbought territory, but buyers still have the upper hand. Significant volume surge after the earnings report, with both price and volume rising, greatly increasing the probability of breaking through 11.80. The upside target is 13.00+, and

$TLRY Cannabis stocks may trigger multiple second-stage investor breakouts today. Reclaiming the 50-day moving average! The price will go up. What are your thoughts on TLRY?🙂

If you were following the news late last night, the Washington Post reported that "Trump's aides are planning to order the reclassification of marijuana as a Schedule III controlled substance, placing it in the same category as prescription painkillers." This caused all cannabis

$SNDL The stock price has recently formed a symmetrical triangle pattern, with the upper boundary being a descending trendline (yellow) and the lower boundary being an ascending support line (blue), a typical bullish consolidation structure. It has broken above the upper

I've been quietly following Tobias Schmidt for a few days, and randomly placed two bets. Last week, I received 13,000 yuan. stock/SNDL/OPEN/NVDA

$AAL Key support level: $15.30-$15.50 Resistance level: $17.00-$17.50 Target price may be revised upwards to $19. If the stock price breaks above $17 with increased trading volume, and the price is above the 50-day moving average, with the short-term RSI indicator approaching the

$SPIR Target Price: $12-14 Stop-Loss Price: $6.50-6.80 Although short-term earnings are under pressure due to business adjustments, sentiment is depressed but oversold, and long-term growth driven by orders is highly certain.

$MLKN Target Price: $20-22 Stop Loss: $16.30 (This is a support level; close your position if the price breaks below this level to avoid further declines.) The company's earnings exceeded expectations, and strong order growth indicates significant potential for a short-term